<DOC>
	<DOCNO>NCT02433873</DOCNO>
	<brief_summary>The primary purpose study evaluate effect IMO nutritional supplement gut microbiome , gut health , body weight . Two formulation supplement evaluate ; thus , three study arm : Supplement A , Supplement B , placebo . Stool sample analyze bacterial DNA . The gut bacterial DNA , body weight , gut health data compare across supplement placebo group . Primary Aim 1 : To evaluate effect IMO supplement gut bacterial abundance , diversity , gene function across intervention placebo group , across two dos intervention . Secondary Aim 1 : To evaluate effect IMO supplement gut health across intervention placebo group , across two dos intervention . Secondary Aim 2 : To evaluate effect IMO supplement body weight across intervention placebo group , across two dos intervention . 60 subject , randomize three arm ( 20 : Supplement formula A , Supplement formula B placebo ) take daily dose Supplement A , Supplement B , placebo 8 week . The supplement light syrup liquid . Ingredients supplement : isomalto-oligosaccharide , water , mannitol , maltose , glucose , glycerol . Ingredients placebo : high maltose corn syrup ( Satin Sweet™ ) , water , mannitol . Dose 500 mg first 4 week 1000 mg second 4 week . Subjects instruct take 500 mg/day supplement placebo first four week 1000 mg/day supplement placebo second four week . Subjects blind whether receive placebo supplement . After screen enrol , subject involvement include visit George Mason University , weigh , drop stool sample , complete survey gut health . Stool sample analyze bacterial DNA . The gut bacterial DNA , weight , gut health data compare across supplement placebo group .</brief_summary>
	<brief_title>Prebiotic Effects Isomalto-oligosaccharide</brief_title>
	<detailed_description />
	<criteria>Provide sign date informed consent form Willing comply study procedure available duration study Male female , age 18 45 year age In good general health evidence medical history Women reproductive potential must use highly effective contraception Body mass index 25 kg/m2 high Weigh less 350 lb . History colon cancer History rheumatoid arthritis Active selfreported febrile illness ( may enroll 2week wait period follow day illness/fever resolve ) Taking TNFalpha inhibitor , COX2 inhibitor , JAK inhibitor History hypothyroidism ( without treatment ) History inflammatory bowel disease ( ulcerative colitis Crohn 's disease ) Type I Type II diabetes History Parkinson 's Disease , Huntington 's Disease Multiple Sclerosis History major depression , bipolar disorder , schizophrenia Pregnant lactate woman Currently suffer migraine headache ( least one migraine headache past 30 day ) Current use prescription nonprescription weight loss product Consumption 2 drink per day alcohol Tobacco smoker ( ½ pack per week exclude ) Marijuana smoker ( per month exclude ) Currently eat disorder include anorexia nervosa , bulimia , and/or obsessive compulsive disorder Plan start new diet make change current diet study Diagnosis Coronary Artery Disease chest pain within past 2 month Diagnosis Congestive Heart Failure episodes shortness breath within last 2 month History stroke within past 1 year History ventricular tachycardia fibrillation History hypertension difficult control medication ( base medical history e.g . require 2 medication achieve control ) History seizures last 5 year Cancer diagnosis last 5 year ( except nonmelanoma skin cancer insitu cervical cancer ) History bariatric lapband surgery Usual plan consumption 2 serving per week yogurt , kombucha , kefir , kimichi Regular use antibiotic Use antibiotic previous 2 week Current continue use prebiotics probiotic Known allergic reaction component study supplement placebo</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Microbiota</keyword>
	<keyword>Body weight</keyword>
	<keyword>Digestive system</keyword>
</DOC>